In this episode of Psychedelics Weekly, David is joined by Kathryn L. Tucker, JD: Director of Advocacy at the National Psychedelics Association and a founding member of the Psychedelic Bar Association with over 35 years in advocacy in protecting the rights of dying patients.  Tucker is currently working with Dr. Sunil Agarwal of the Advanced […]

The post Psychedelics Weekly – AIMS vs. the DEA: An Update on the Fight to Reschedule Psilocybin appeared first on Psychedelics Today.

Previous articleEstablishing the Psychedelic Research Center Consortium​
Next articleMYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT